CAPE EMS Bhd has unveiled the completion of a contract manufacturing agreement and an initial project addendum with American life science and clinical research outfit Thermo Fisher Scientific which marks a significant milestone in the technology developed by its wholly owned subsidiary iConn Technologies.
The agreement was fully executed by the Main Market-listed electronics manufacturing and engineering solutions outfit on Oct 20 after the deal came into effect on Aug 20 while the initial addendum was fully executed on Nov 2 after it came into effect from Oct 23.
The relationship was developed over four years by iConn Technologies which is led by its CEO Turker Hidirlar. The milestone advances the group’s life sciences expansion within its Intelligent Manufacturing Network strategy.
The agreement inked between Hidirlar on behalf of Cape EMS and Thermo Fisher Scientific’s vice-president (procurement) has an initial three-year term with up to two further one-year extensions by mutual agreement.
The engagement involves multiple Thermo Fisher Scientific life sciences businesses and follows an extensive evaluation and contract development process with its global procurement team and participating businesses.
![]()
iConn’s engagement spans research and development support and production activities in the US, Europe and Asia.
The work encompasses technically demanding components, complex electromechanical assemblies, finished products and integrated systems.
Working alongside customer teams, iConn addresses technical challenges and develops manufacturing methodologies, including work focused on improving production yields and manufacturability.
The agreements build on an established commercial relationship involving recurring monthly supply, production and first-article parts as well as research and development engagements across selected Thermo Fisher Scientific businesses.
Purchase orders have been received and fulfilled with on-going activities spanning engineering support and manufacturing execution. The award relating to the initial signed project addendum was communicated in May 2026.
“For CAPE EMS and iConn, this agreement is strategically important and reflects the relationship that Turker and the iConn team have developed through sustained customer engagement and project execution,” commented Cape EMS’ group CEO Christina Tee.

“It advances our life sciences expansion within the Intelligent Manufacturing Network pillar and contributes to the group’s broader CEB (Cape EMS Bhd) 2.0 transformation.”
Added Tee: “We see an opportunity to strengthen Malaysia’s role in advanced life sciences development and manufacturing, supported by the expertise and resources of our international network.”
Turker Hidirlar, Chief Executive Officer of iConn Technologies, said:
“This milestone represents four years of focused work developing the relationship and progressing customer projects. Purchase orders across multiple Thermo Fisher Scientific businesses, according to iConn CEO Hidirlar.
“Our role is to manage complexity across development and manufacturing, bringing together the expertise and resources needed to address demanding customer requirements,” he revealed.

“Our priority is dependable execution against existing commitments while developing capabilities to support the relationship over time.”
iConn has been preparing through targeted capability development, specialist recruitment and capacity planning. Selected engineering and operational resources have been allocated to execution.
Through its Intelligent Manufacturing Network, iConn coordinates engineering expertise and manufacturing resources across international locations.
Cape EMS Group operates across four core pillars: (i) Electronic Manufacturing Services (EMS); (ii) Intelligent Manufacturing Network; (iii) Renewable Energy; and (iv) Internet of Things.
Life sciences expansion through iConn forms part of the group’s broader portfolio and growth strategy.
At the close of today’s (Nov 16) mid-day trading, Cape EMS was down 0.5 sen or 1.89% to 26 sen with 8.42 million shares traded, thus valuing the company at RM277.2 mil. – Nov 16, 2026
Main image credit: Investopedia




